This Week in the Circuits: Second Circuit to Mull Parents’ Claims on Tylenol’s Link to Autism

Welcome to This Week in the Circuits, a look at the most significant cases before federal appeals courts.

Parents suing makers and sellers of Tylenol and generic acetaminophen will urge the Second Circuit on Monday to revive claims that the drugs’ labels are deficient, based on allegations that the painkillers are linked to a higher risk of autism.

The pair of arguments before the US Court of Appeals for the Second Circuit come after the Trump administration in September warned pregnant women against taking Tylenol over an alleged risk of causing autism in children, despite a lack of widely-accepted supporting ...